Drug Patents owned by Athena

1. List of Fibricor drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7569612 ATHENA Methods of use of fenofibric acid
Aug, 2027

(4 years from now)

US7741373 ATHENA Methods of use of fenofibric acid
Aug, 2027

(4 years from now)

US7915247 ATHENA Methods of use of fenofibric acid
Aug, 2027

(4 years from now)

US7741374 ATHENA Methods of use of fenofibric acid
Aug, 2027

(4 years from now)

Drugs and Companies using FENOFIBRIC ACID ingredient

Market Authorisation Date: 14 August, 2009

Treatment: Adjunctive therapy to diet in patients with hyperlipidemias; Adjunctive therapy to diet to patients with hypertriglyceridemia; Adjunctive therapy to diet in patients with mixed dyslipidemia; Adjunctive therapy to diet in patients with elevated cholesterol and/or lipid levels

Dosage: TABLET;ORAL

More Information on Dosage

2. List of Nexiclon Xr drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8337890 ATHENA Modified release formulations containing drug-ion exchange resin complexes
Apr, 2027

(4 years from now)

US8623409 ATHENA Clonidine formulation
Sep, 2031

(8 years from now)

Drugs and Companies using CLONIDINE ingredient

Market Authorisation Date: 03 December, 2009

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

3. List of Qdolo drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11103452 ATHENA Tramadol hydrochloride solution
Sep, 2040

(17 years from now)

Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient

Market Authorisation Date: 01 September, 2020

Treatment: Management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate

Dosage: SOLUTION;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in